Janssen Pharmaceutical K.K. Opens R&D Center in Shanghai
2/6/2013 10:21:08 AM
More...
|
NGM Biopharmaceuticals, Inc., Janssen Pharmaceutical K.K. Form Alliance for Undisclosed Amount
1/3/2013 8:05:32 AM
More...
|
Evotec AG (EVTG.F), Janssen Pharmaceutical K.K. Sign License Agreement for Up to $175 Million
12/17/2012 7:26:16 AM
More...
|
FDA Approves Janssen Pharmaceutical K.K.'s NUCYNTA® ER (tapentadol) Extended-Release Oral Tablets for Neuropathic Pain
8/29/2012 7:01:54 AM
More...
|
Janssen Pharmaceutical K.K. Release: Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN)
5/18/2012 10:55:53 AM
More...
|
Watson Pharmaceuticals, Inc. (WPI) Reaches Settlement With Janssen Pharmaceutical K.K. Over ORTHO TRI-CYCLEN(R) LO
2/8/2012 10:55:13 AM
More...
|
Orexo AB, Janssen Pharmaceutical K.K. Axe Preclinical-Stage Deal in Respiratory Diseases
1/31/2012 6:59:53 AM
More...
|
Record Breaking $327 Million Verdict Upheld in Janssen Pharmaceutical K.K. Case and Request for New Trial Denied
12/21/2011 8:11:09 AM
More...
|
Synexus' Pretoria Clinical Research Site Delivers World Beating Performance for Janssen Pharmaceutical K.K.
10/24/2011 11:39:05 AM
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE), Janssen Pharmaceutical K.K. to Co-Promote VELCADE(R) (bortezomib) for Injection in Japan
5/10/2010 6:54:58 AM
More...
|